News

Company   ImmuPharma PLC
TIDM         IMM
Headline    Directors' Dealing
Released    16:17 13-Aug-07
Number     0086C

FOR IMMEDIATE RELEASE

London, 13 August 2007

Directors’ Dealing

ImmuPharma plc (LSE:IMM), ("ImmuPharma" or the "Company"), received notification of a private placement of existing shares to institutions and private investors, including Quest Management, Morley, Odey Asset Management, Cheviot and Celeste. The shares were placed to satisfy demand and increase liquidity, from the holdings of two of the founding Directors.

The placement was handled by Cornhill Asset Management Limited. The directors also each granted Cornhill Asset Management Limited an option to purchase up to 200,000 additional shares at £1.00 [per share].

The Directors’ interests are as follows

	Shares Placed	Price per share	Subsequent beneficial holding	Subsequent percent interest
Richard Warr⁽¹⁾	1,638,500	£0.70	12,778,968	17.6%
Dimitri Dimitriou⁽²⁾	1,638,500	£0.70	12,778,969	17.6%

(1) Ordinary shares of £0.10 held by Louvre Trustees where the Warr family has a beneficial interest.
(2) Ordinary shares of £0.10 held by Hawthorn Invest Ltd where the Dimitriou family has a beneficial interest.

The Company also announces, that the name of the Company’s nominated adviser and broker has changed to Landsbanki Securities (UK) Limited, which follows a name change from Teather & Greenwood Limited to Landsbanki Securities UK Limited on 9 August 2007.

For further information please contact:

ImmuPharma PLC

Richard Warr, Chairman +44 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer +44 20 7152 4080

Buchanan Communications + 44 20 7466 5000

Lisa Baderoon
Rebecca Skye-Dietrich

Landsbanki Securities (UK) Limited +44 20 7426 7710

Thilo Hoffmann